Last update 15 Jul 2025

Mitiglinide Calcium/Metformin Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Metgluna, Mitiglinide/metformin
Target
PRKAB1 x Potassium channel x VGKCs
Action
activators, blockers
Mechanism
PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators), Potassium channel blockers, VGKCs blockers(Voltage-gated potassium channel blockers)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Diabetes MellitusDiabetes Mellitus, Type 2
Originator Organization
Kissei Pharmaceutical Co., Ltd.Kissei Pharmaceutical Co., Ltd.
Active Organization-
Inactive Organization
Kissei Pharmaceutical Co., Ltd.Kissei Pharmaceutical Co., Ltd.JW PHARMACEUTICAL Corp.JW PHARMACEUTICAL Corp.Elixir Pharmaceuticals, Inc.Elixir Pharmaceuticals, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC4H12ClN5
InChIKeyOETHQSJEHLVLGH-UHFFFAOYSA-N
CAS Registry1115-70-4
View All Structures (2)

Related

1
Clinical Trials associated with Mitiglinide Calcium/Metformin Hydrochloride
NCT01443221
/ CompletedPhase 1
Open-label, Randomized, Single-dose, 2-way Crossover Study to Investigate Safety and Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.
100 Clinical Results associated with Mitiglinide Calcium/Metformin Hydrochloride
Login to view more data
100 Translational Medicine associated with Mitiglinide Calcium/Metformin Hydrochloride
Login to view more data
100 Patents (Medical) associated with Mitiglinide Calcium/Metformin Hydrochloride
Login to view more data
100 Deals associated with Mitiglinide Calcium/Metformin Hydrochloride
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 3
United States
Elixir Pharmaceuticals, Inc.Elixir Pharmaceuticals, Inc.
-
Diabetes Mellitus, Type 2Phase 3-
Kissei Pharmaceutical Co., Ltd.Kissei Pharmaceutical Co., Ltd.
-
Diabetes MellitusPhase 1
United States
JW PHARMACEUTICAL Corp.JW PHARMACEUTICAL Corp.
01 Dec 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free